trending Market Intelligence /marketintelligence/en/news-insights/trending/fxzfikoklmkhmgfm_aw1mq2 content esgSubNav
In This List

Guggenheim Securities names senior biotech analyst

Blog

Banking Essentials Newsletter: July Edition - Part 3

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

Banking Essentials Newsletter: July Edition - Part 2


Guggenheim Securities names senior biotech analyst

Michael Schmidt will join Guggenheim Securities in June as a senior analyst and senior managing director as part of the company's expansion of its healthcare research team.

Schmidt will focus on the coverage of biotech companies and will work closely with its therapeutics team.

He has served as an equity research analyst at LEERINK Partners since 2009.

Guggenheim Securities is the investment banking and capital markets division of Guggenheim Partners.